RAPT Therapeutics Inc at JPMorgan Healthcare Conference Transcript
All right. Let's go ahead and get started. Welcome, everyone, to the 42nd Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Priyanka Grover, Malcolm Kuno, and LaRhea Hall. Our next presenting company is RAPT, and presenting on behalf of the company, we have CEO, Brian Wong. Brian?
Thanks for the introduction, Anupam, and Happy New Year, everyone. Thanks for your interest in RAPT Therapeutics. Actually, joining me from the company today is Rodney Young, our Chief Financial Officer; and Sylvia Wheeler, who leads our IR efforts here as well.
So just to provide some context on the company, RAPT is focused on the discovery, development, and commercialization of oral, small-molecule drugs. The target, the fundamental drivers of inflammation and cancer. We have an in-house proprietary discovery engine that has enabled the rapid progression of a diversified and clinically de
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |